RECENT HEADLINES

October 11, 2023

Cellipont Bioservices and Evia Bio Collaborate to Launch Cryo Excellence Center (CryoX) in Houston, TX

October 10, 2023

Cellipont Bioservices and Diakonos Oncology Corporation Collaborate to Develop Groundbreaking Therapy for Glioblastoma

June 8, 2023

As new cell therapy facility in The Woodlands approaches readiness, Cellipont adds new Site Operations Head

June 5, 2023

Madhavi Anumula Joins Cellipont to Lead Process Development Group

March 21, 2023

Cellipont Receives Strategic Debt Investment from OrbiMed to Complete State-of-the-Art Commercial Manufacturing Facility

February 27, 2023

Cellipont Announces Additions to Commercial Leadership Team

November 10, 2022

Cellipont Bioservices Celebrates Groundbreaking for New Commercial-Ready Cell Therapy Facility in The Woodlands, Texas

September 6, 2022

Cellipont Names New Chief Scientific Officer

August 17, 2022

Cellipont Announces Plans for Commercial-Ready Facility in Houston 

August 15, 2022

Cellipont to Exhibit at CAR-TCR Summit in Boston

May 11, 2022

Cellipont Announces Cell Therapy Facility Expansion To Support Growth

April 15, 2022

Cellipont to Exhibit at ASGCT 25th Annual Meeting

April 4, 2022

Cellipont COO Mike O’Mara Featured in Contract Pharma “CDMO Trends” Article

Article in “Contract Pharma” Magazine

March 15, 2022

Cellipont Bioservices Announces Additions to Senior Leadership Team

March 10, 2022

Lessons Learned: An Inside Look At Overcoming Stem Cell Therapy Scale-up

Article co-published with Corning Life Sciences in Cell & Gene Online (free registration required)

January 12, 2022

FIERCE PHARMA: Performance Cell picked up by private equity firm, rebrands as Cellipont Bioservices

January 11, 2022

Cellipont Bioservices announces acquisition and re-branding